Akari Therapeutics Plc (AKTX)
9.105
+0.92
(+11.31%)
USD |
NASDAQ |
Oct 19, 16:00
9.00
-0.10
(-1.15%)
After-Hours: 16:14
Akari Therapeutics Cash from Operations (Annual) : -10.59M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -10.59M |
| December 31, 2024 | -12.56M |
| December 31, 2023 | -16.43M |
| December 31, 2022 | -21.50M |
| December 31, 2021 | -18.85M |
| December 31, 2020 | -16.95M |
| December 31, 2019 | -12.97M |
| December 31, 2018 | -22.58M |
| Date | Value |
|---|---|
| December 31, 2017 | -31.60M |
| December 31, 2016 | -24.52M |
| December 31, 2015 | -4.964M |
| December 31, 2014 | -9.423M |
| December 31, 2013 | -5.45M |
| December 31, 2012 | -2.127M |
| December 31, 2011 | -1.007M |
| December 31, 2010 | -0.3665M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| DBV Technologies SA | -121.56M |
| Cellectis SA | -40.14M |
| Bicycle Therapeutics Plc | -250.26M |
| argenx SE | 850.49M |
| Autolus Therapeutics Plc | -284.23M |